Sky Medical technology, the parent company of medical device firm Firstkind Ltd., has been named the Most Innovative MedTech Company 2020 at the International Life Sciences Awards.
Sky Medical technology has developed OnPulse, a non-invasive technology platform embedded in its geko device. The geko device is a neuromuscular electrostimulation device designed to prevent blood stasis in the deep veins of the calf through activation of muscle pumps in the feet and calves, achieved through stimulating the common peroneal nerve.
The device weighs just 10g, operates silently and, being battery powered, requires no leads or wires. It is recommended for VTE prophylaxis in hospital patients for whom standard treatments are impractical or contraindicated.
Sky Medical Technology Founder and CEO Bernard Ross commented: "It's wonderful to be recognised for innovation, through the impact that our technology, the geko device, is having in the treatment of a range of medical conditions. As we continue to face down this COVID-19 health crisis, it's essential that clinicians across the health and life sciences sector can turn to medical device innovation to overcome these challenges.”
"We aim to be innovative in every area of our business from our leading product, the geko device, to our manufacturing processes, our route to market via global distributors and partnerships with clinicians across the globe. We'd like to thank the International Life Sciences Award for recognising our innovation in the sector."